Unlike many other tumor entities such as lung cancers (Shibata et al., 2008; Kim et al., 2010), however, PDACs rarely harbor somatic mutations in either the KEAP1 or NRF2 genes that usually result in an active NRF2. This evidence concerns the gene NFE2L2 and neoplasm.